Polich, J, Moore, A P, Wiederhold, M D · Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society · 1995 · DOI
Quick Summary
This study measured electrical activity in the brains of people with ME/CFS and healthy controls using a simple listening task where they had to identify specific sounds. Researchers found no differences in brain wave patterns (called P300) between the two groups, even though many ME/CFS patients report problems with memory and attention. This suggests that brain electrical activity measured this way may not be a reliable marker for ME/CFS.
Why It Matters
Brain biomarkers could potentially help validate ME/CFS as a physiological condition and support patients in diagnosis and treatment planning. Understanding why cognitive symptoms persist despite normal brain electrical responses to attention-demanding tasks provides important insights into ME/CFS pathophysiology and helps researchers identify which brain measures may or may not be useful for diagnosis.
Observed Findings
No significant differences in P300 amplitude between CFS patients and controls across any stimulus probability condition
No significant differences in P300 latency between groups
No group differences in earlier ERP components (N1, P2, N2)
Auditory tone-discrimination task successfully elicited measurable ERPs in both groups
Inferred Conclusions
Auditory P300 event-related potentials are not a reliable discriminator between CFS patients and healthy controls
Cognitive complaints in CFS may not be reflected in this particular measure of attention-related brain electrical activity
Other neurobiological markers or assessment methods may be needed to identify objective measures of CFS-related cognitive dysfunction
Remaining Questions
Why do ME/CFS patients report attention and memory problems if standard P300 measures appear normal?
Would other types of cognitive tasks (visual, more complex, or longer duration) produce different ERP results?
Are there other brain electrical measures or imaging techniques that better correlate with cognitive symptoms in ME/CFS?
What This Study Does Not Prove
This study does not prove that ME/CFS patients do not have real cognitive deficits—only that this particular brain measurement does not detect them. The absence of P300 differences does not rule out abnormalities in other brain systems, brain regions, or different types of cognitive testing. A negative finding in one biomarker does not indicate cognitive complaints are non-neurological.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:Neuroimaging
Method Flag:Weak Case DefinitionSmall SampleExploratory Only